GILD
$GILD
Gilead Sciences, Inc.
Biopharmaceutical company focused on HIV, hepatitis, and oncology.
Healthcare$139.73
-0.57 (-0.41%)
Day Range$138.64 - $141.34
Prev Close$140.30
Analyst Rating
Strong Buy
31 Buy / 8 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Apr 5
Weekly updates
Latest Report
GILD: Re-rating, Trodelvy Upside, and M&A Questions
Gilead ($GILD) trades at $135.38 with a 2.44% yield, a P/E near 19.6 and broad analyst optimism. Recent re-rating and new concentration risks create a mixed setup ahead of Q1 results.
Mar 30, 2026